NCT06146413View on ClinicalTrials.gov

Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 30, 2023

Primary Completion Date

March 30, 2025

Study Completion Date

December 30, 2025

Conditions
Infertility
Interventions
DRUG

Double trigger

GnRH agonist ( Triptorelin ) ( 0.2 mg / S.C ) and hCG ( 10000 IU) are administered 40 and 34 h before ovum pick-up

DRUG

HCG trigger

hCG ( 10000 IU) is administered 36 h before ovum pick-up

Trial Locations (1)

Unknown

Bedaya Hospital, Giza

All Listed Sponsors
lead

Bedaya Hospital

OTHER